Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

Filana Therapeutics Inc Is A Biotechnology Company Focused On Developing Novel, Investigational Therapies To Modulate The Filamin A Protein For The Treatment Of Central Nervous System Disorders, Such As Tuberous Sclerosis Complex (Tsc)-Related Epilepsy, And Other Diseases Associated With Dysregulation Or Overexpression Of Filamin A. Its Therapeutic Product Candidate, Simufilam, Is A Proprietary Small Molecule Oral Treatment Drug Being Studied For The Treatment Of Tsc-Related Epilepsy.